基本信息
浏览量:212
职业迁徙
个人简介
After graduating from Kobe University Graduate school of Medicine, Dr. Miyake joined the Vancouver Prostate Centre as a postdoctoral fellow in 1998. He worked with Dr. Martin Gleave investigating the molecular mechanisms involved in the progression of prostate cancer to androgen-independence and the development of a novel therapeutic strategy targeted against antiapoptotic genes using antisense oligonucleotide technology. To date, he has published more than 300 peer-reviewed papers, including 46 under joint authorship with Dr. Gleave. He is a recipient of many awards, such as the First prize in the Essay Contest at the CUA annual meeting in 1999, First prize in the Essay Contest at the AUA annual meeting in 2000 and Best Paper Award of the Clinical Section at the JUA annual meeting in 2008.
Dr. Miyake’s current research focuses on a wide range of topics associated with urological oncology, including the role of inflammatory cytokines as activators of androgen receptor, the impact of the prostate's microenvironment on local aggressiveness of prostate cancer and the overcoming of acquired resistance of renal cancer to molecular targeted agents. Moreover, he has tried to develop novel therapies for urological cancers by combining conventional therapeutic modalities and OGX-011, an antisense oligonucleotide inactivating the cytoprotective chaperon clusterin, in collaboration with Dr. Gleave.
Dr. Miyake is currently playing a central role in the Division of Urology, Kobe University Hospital as a clinical scientist and urologic surgeon. Therefore, he is also performing a number of clinical studies focusing on a wide variety of interesting topics, such as the development of extended radical prostatectomy for locally advanced prostate cancer, the improvement of functional outcomes in bladder cancer patients with orthotopic neobladder and the assessment of useful sequential therapy for metastatic renal cancer using molecular targeted agents. In addition, as the Chair of the Urological Oncology Group at Kobe University Hospital, he provides access for patients with urological cancer to the latest clinical trials using novel drugs.
研究兴趣
论文共 726 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hideaki Miyake, Rikiya Matsumoto,Kiyohide Fujimoto,Atsushi Mizokami,Hirotsugu Uemura,Toshiyuki Kamoto,Satoru Kawakami,Kazuyoshi Nakamura,Shigekatsu Maekawa,Kazuhiro Shibayama, Aki Watanabe, Miku Ito,
European Urology Oncology (2024)
Ryo Sato,Yuto Matsushita,Ayana Takemura, Momoko Sugiyama,Kyohei Watanabe,Hiromitsu Watanabe,Keita Tamura,Daisuke Motoyama, Masao Nagata,Atsushi Otsuka, Hiroshi Furuse,Hideaki Miyake
Anticancer researchno. 2 (2024): 781-786
INTERNATIONAL JOURNAL OF UROLOGY (2024)
International journal of urology : official journal of the Japanese Urological Association (2024)
Anticancer Researchno. 4 (2024): 1417-1423
INTERNATIONAL JOURNAL OF UROLOGY (2024)
Tomoya Yamaguchi,Hiroki Yabe, Takayuki Sugiyama, Shinsuke Isobe, Yuma Hirano,Hideo Yasuda,Hideaki Miyake,Katsuya Yamauchi
Renal Replacement Therapyno. 1 (2024): 1-6
Respiratory Researchno. 1 (2024): 25-25
IJU case reportsno. 2 (2023): 96-99
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn